Permissive Cardiotoxicity: When the Optimal Is the Enemy of the Good
Cancer and cardiovascular diseases are the leading causes of mortality worldwide.As these diseases share common metabolic pathways, patients with cancer are currently seen as having subclinical alterations with great potential for developing cardiovascular diseases (and vice versa).This tenuous interrelationship has led to the emergence of cardiooncology (CO) as an area of study and discussion, with a major impact on the management of these cases.In clinical practice, CO is dominated by the dilemma of how to best manage cardiovascular toxicity during cancer Central Illustration: Permissive Cardiotoxicity: When the Optimal Is the Enemy of the Good Imagem Cardiovascular ABC
Authors
- Ana Palmira Lima Neves (ORCID: https://orcid.org/0000-0003-4681-6585)
- Ariane Vieira Scarlatelli Macedo (ORCID: https://orcid.org/0000-0002-3453-8488)
- Carolina Maria Pinto Domingues Carvalho Silva (ORCID: https://orcid.org/0000-0003-0602-6167)
- Juliane Dantas Seabra-Garcez (ORCID: https://orcid.org/0000-0002-1645-1186)
Publication Details
- Journal
- ARQUIVOS BRASILEIROS DE CARDIOLOGIA - IMAGEM CARDIOVASCULAR
- Published
- 2025-01-01
- DOI
- https://doi.org/10.36660/abcimg.20240115i
- Citations
- 1
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 1.39